Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.990
+0.100 (3.46%)
Nov 4, 2024, 4:00 PM EST - Market closed

BDTX Statistics

Total Valuation

BDTX has a market cap or net worth of $168.95 million. The enterprise value is $69.76 million.

Market Cap 168.95M
Enterprise Value 69.76M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date Nov 15, 2024
Ex-Dividend Date n/a

Share Statistics

BDTX has 56.50 million shares outstanding. The number of shares has increased by 43.95% in one year.

Shares Outstanding 56.50M
Shares Change (YoY) +43.95%
Shares Change (QoQ) +6.46%
Owned by Insiders (%) 2.31%
Owned by Institutions (%) 75.36%
Float 44.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.52
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.87, with a Debt / Equity ratio of 0.21.

Current Ratio 6.87
Quick Ratio 6.67
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -83.38% and return on invested capital (ROIC) is -44.74%.

Return on Equity (ROE) -83.38%
Return on Assets (ROA) -40.41%
Return on Capital (ROIC) -44.74%
Revenue Per Employee n/a
Profits Per Employee -$1.49M
Employee Count 54
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +57.37% in the last 52 weeks. The beta is 2.52, so BDTX's price volatility has been higher than the market average.

Beta (5Y) 2.52
52-Week Price Change +57.37%
50-Day Moving Average 4.35
200-Day Moving Average 4.89
Relative Strength Index (RSI) 35.32
Average Volume (20 Days) 767,657

Short Selling Information

The latest short interest is 7.32 million, so 12.96% of the outstanding shares have been sold short.

Short Interest 7.32M
Short Previous Month 6.91M
Short % of Shares Out 12.96%
Short % of Float 16.46%
Short Ratio (days to cover) 3.06

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -87.24M
Pretax Income -80.55M
Net Income -80.55M
EBITDA -86.87M
EBIT -87.24M
Earnings Per Share (EPS) -$1.54
Full Income Statement

Balance Sheet

The company has $122.97 million in cash and $23.78 million in debt, giving a net cash position of $99.19 million or $1.76 per share.

Cash & Cash Equivalents 122.97M
Total Debt 23.78M
Net Cash 99.19M
Net Cash Per Share $1.76
Equity (Book Value) 111.02M
Book Value Per Share 1.97
Working Capital 108.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.24 million and capital expenditures -$33,000, giving a free cash flow of -$68.28 million.

Operating Cash Flow -68.24M
Capital Expenditures -33,000
Free Cash Flow -68.28M
FCF Per Share -$1.21
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BDTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -43.95%
Shareholder Yield -43.95%
Earnings Yield -47.68%
FCF Yield -40.41%

Analyst Forecast

The average price target for BDTX is $15.50, which is 418.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.50
Price Target Difference 418.40%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -25.84%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2